Katherine Fuh

Publications

• Ridiculously Good Writing: How to Write Like a Pro and Publish Like a Boss
  Gynecologic Oncology Reports. Aug, 2022  |   Pubmed ID: 35719321
• Author Correction: Comprehensive Characterization of 536 Patient-derived Xenograft Models Prioritizes Candidates for Targeted Treatment
  Nature Communications. Jan, 2022  |   Pubmed ID: 34996889
• Culturing Primary Human Mesothelial Cells
  Methods in Molecular Biology (Clifton, N.J.). 2022  |   Pubmed ID: 34918292
• GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition Through Increased DNA Damage and Enhanced Replication Stress
  Molecular Cancer Research : MCR. Feb, 2022  |   Pubmed ID: 34670865
• Phase 1b Study of AVB-500 in Combination with Paclitaxel or Pegylated Liposomal Doxorubicin Platinum-resistant Recurrent Ovarian Cancer
  Gynecologic Oncology. Nov, 2021  |   Pubmed ID: 34474927
• Comprehensive Characterization of 536 Patient-derived Xenograft Models Prioritizes Candidatesfor Targeted Treatment
  Nature Communications. Aug, 2021  |   Pubmed ID: 34429404
• Entinostat, a Selective HDAC1/2 Inhibitor, Potentiates the Effects of Olaparib in Homologous Recombination Proficient Ovarian Cancer
  Gynecologic Oncology. Jul, 2021  |   Pubmed ID: 33867143
• Obese Endometrial Cancer Survivors' Perceptions of Weight Loss Strategies and Characteristics That May Influence Participation in Behavioral Interventions
  Gynecologic Oncology Reports. May, 2021  |   Pubmed ID: 33665293
• Homologous Recombination Deficiency Real-time Clinical Assays, Ready or Not?
  Gynecologic Oncology. Dec, 2020  |   Pubmed ID: 32967790
• FIGO 2018 Staging Criteria for Cervical Cancer: Impact on Stage Migration and Survival
  Gynecologic Oncology. Jun, 2020  |   Pubmed ID: 32248993
• Proteogenomic Characterization of Endometrial Carcinoma
  Cell. Feb, 2020  |   Pubmed ID: 32059776
• Differences in Presentation and Survival of Asians Compared to Caucasians with Ovarian Cancer: An NRG Oncology/GOG Ancillary Study of 7914 Patients
  Gynecologic Oncology. Aug, 2019  |   Pubmed ID: 31229298
• P5RHH Nanoparticle-mediated Delivery of AXL SiRNA Inhibits Metastasis of Ovarian and Uterine Cancer Cells in Mouse Xenografts
  Scientific Reports. Mar, 2019  |   Pubmed ID: 30886159
• [Not Available]
  Gynecologic Oncology Reports. Feb, 2019  |   Pubmed ID: 30582746
• Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer
  Molecular Cancer Therapeutics. Feb, 2019  |   Pubmed ID: 30478151
• AXL Modulates Extracellular Matrix Protein Expression and is Essential for Invasion and Metastasis in Endometrial Cancer
  Oncotarget. Nov, 2016  |   Pubmed ID: 27764792
• Summary of the 2016 American Association for Cancer Research (AACR) Annual Meeting
  Gynecologic Oncology. Jul, 2016  |   Pubmed ID: 27181388